| 1 |
35173877 | Effect of various doses of rosuvastatin in the treatment of elderly patients with unstable angina pectoris. | 2022 |
2 |
| 2 |
32955957 | Rosuvastatin decreases serum inflammatory markers and slows atherosclerosis progression rate in treated HIV-infected patients with metabolic syndrome. | 2021 Feb |
1 |
| 3 |
33913752 | The Effect of Rosuvastatin on Plasma/Serum Levels of High-Sensitivity C-Reactive Protein, Interleukin-6, and D-Dimer in People Living with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis. | 2021 Nov |
1 |
| 4 |
32652935 | Anti-inflammatory effects of rosuvastatin treatment on coronary artery ectasia patients of different age groups. | 2020 Jul 11 |
1 |
| 5 |
27739345 | Rosuvastatin Inhibits Interleukin (IL)-8 and IL-6 Production in Human Coronary Artery Endothelial Cells Stimulated With Aggregatibacter actinomycetemcomitans Serotype b. | 2017 Feb |
3 |
| 6 |
27846790 | Efficacy comparison of atorvastatin versus rosuvastatin on blood lipid and microinflammatory state in maintenance hemodialysis patients. | 2017 Nov |
1 |
| 7 |
26687339 | Effects of Combination of Ezetimibe and Rosuvastatin on Coronary Artery Plaque in Patients with Coronary Heart Disease. | 2016 May |
1 |
| 8 |
25495178 | Rosuvastatin treatment in stable chronic obstructive pulmonary disease (RODEO): a randomized controlled trial. | 2015 Jul |
1 |
| 9 |
25771851 | Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis. | 2015 Jun |
3 |
| 10 |
26278425 | Rosuvastatin Lowers Systemic Inflammatory Response in Coronary Artery Bypass Graft Accompanied by Cardiopulmonary Bypass Surgery: A Randomized Controlled Study. | 2015 Aug 9 |
1 |
| 11 |
24410968 | Rosuvastatin can block pro-inflammatory actions of transgenic human C-reactive protein without reducing its circulating levels. | 2014 Apr |
1 |
| 12 |
25319951 | Rosuvastatin may reduce the incidence of cardiovascular events in patients with acute coronary syndromes receiving percutaneous coronary intervention by suppressing miR-155/SHIP-1 signaling pathway. | 2014 Dec |
1 |
| 13 |
22999910 | Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. | 2013 Mar |
4 |
| 14 |
23364255 | Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes. | 2013 Jul |
2 |
| 15 |
22555227 | Rosuvastatin might have an effect on C-reactive protein but not on rheumatoid disease activity: Tayside randomized controlled study. | 2012 May |
4 |
| 16 |
18789009 | [Molecular mechanisms of effects of rosuvastatin on systemic oxidative stress and endogenous inflammation in patients with atherosclerosis]. | 2008 |
1 |
| 17 |
17577102 | Rosuvastatin suppresses the inflammatory responses through inhibition of c-Jun N-terminal kinase and Nuclear Factor-kappaB in endothelial cells. | 2007 Jun |
1 |
| 18 |
17595889 | Rosuvastatin reduces interleukin-6-induced expression of C-reactive protein in human hepatocytes in a STAT3- and C/EBP-dependent fashion. | 2007 Jun |
3 |
| 19 |
18082089 | [Rosuvastatin and metformin decrease inflammation and oxidative stress in patients with hypertension and dyslipidemia]. | 2007 Dec |
1 |
| 20 |
18260902 | [Effect of statin therapy on dynamics of vascular endothelial growth factor and fibroblast growth factor in patients with ischemic heart disease]. | 2007 |
1 |
| 21 |
16858347 | [Effect of therapy with rosuvastatin on lipid spectrum, factors of inflammation and endothelial function in patients with ischemic heart disease]. | 2006 |
1 |